Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Pamela Palmer
AddedMar 31, 2024
UpdatedMay 31, 2026
Pamela Palmer

Pamela Palmer

Founder, AcelRx Pharmaceuticals

CrunchbaseLinkedIn

Pamela Palmer's Career

AcelRx Pharmaceuticals
AcelRx Pharmaceuticals

Redwood City, CA, US

Founder
Talphera
Talphera

Redwood City, CA, US

Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Pamela Palmer's Career

AcelRx Pharmaceuticals
AcelRx Pharmaceuticals
Acquired02005Redwood City, CA, US
Founder

Leadership at AcelRx Pharmaceuticals

Mark WanMark WanBoard Member
Steve HoffmanSteve HoffmanBoard Member
Adrian AdamsAdrian AdamsBoard Member

Similar to AcelRx Pharmaceuticals

Axsome TherapeuticsAxsome TherapeuticsNew York City, NY, USTherapeuticsest. 2012Axsome TherapeuticsNew York City, NY, US · est. 2012

American biopharmaceutical firm, Axsome Therapeutics, develops therapies for pain and neurological disorders globally.

Public · $432M383
Acadia PharmaceuticalsAcadia PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 1993Acadia PharmaceuticalsSan Diego, CA, US · est. 1993

ACADIA Pharmaceuticals: A San Diego-based biopharmaceutical company specializing in CNS disorder treatments.

Public513
TalpheraTalpheraRedwood City, CA, USPain Management, Pharmaceuticalsest. 2005TalpheraRedwood City, CA, US · est. 2005

Talphera, a specialty pharmaceutical firm in Redwood City, develops and commercializes therapies, including innovative pain management systems.

Public · $191.7M37
AkelosAkelosNew York City, NY, USDrug Developmentest. 2018AkelosNew York City, NY, US · est. 2018

Akelos, a NY-based biopharmaceutical company, develops innovative non-opioid drugs for neuropathic pain treatment.

Seed · $2.1M5
Talphera
Talphera
Public$191.7M372005Redwood City, CA, US
Founder

Leadership at Talphera

Howard B. RosenHoward B. RosenBoard Member
Vincent J. AngottiVincent J. AngottiCEO
Pamela P PalmerPamela P PalmerBoard Member

Similar to Talphera

Pacira BioSciencesPacira BioSciencesTampa, FL, USPain Management, Pharmaceuticalsest. 2007Pacira BioSciencesTampa, FL, US · est. 2007

Pacira BioSciences, a Tampa-based medical firm, offers non-opioid pain management and regenerative health solutions in the US.

Public797
ToralgenToralgenIndianapolis, IN, USDrug Deliveryest. 2017ToralgenIndianapolis, IN, US · est. 2017

Toralgen, an Indianapolis-based biopharmaceutical company, innovates in nanopill technology for improved drug delivery.

Seed · $10.2M5
Talima TherapeuticsTalima TherapeuticsSan Carlos, CA, USDrug Deliveryest. 2004Talima TherapeuticsSan Carlos, CA, US · est. 2004

Talima Therapeutics, Inc.: A US-based medical company specializing in site-specific drug delivery systems.

Series B · $20.6M2
TrigeminaTrigeminaMoraga, CA, USPain Treatmentsest. 2006TrigeminaMoraga, CA, US · est. 2006

Trigemina, Inc.: A US-based pharmaceutical company innovating non-opiate pain therapies.

Series A · $27.6M11

Pamela Palmer's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Pamela Palmer

John WelchJohn WelchCo-Founder · TalloTyler StatonTyler StatonCo-Founder · TaloxMichael JungMichael JungCo-Founder · Pelage Pharmachantell Johnsonchantell JohnsonFounder · ThalesDavid NathansonDavid NathansonCo-Founder · TretheraPhoebe TanPhoebe TanCo-Founder · Taelor